Differential antagonism of tetramethylenedisulfotetramine-induced seizures by agents acting at NMDA and GABAA receptors

Toxicology and Applied Pharmacology

Volumn 265, Issue 1, 2012, Pages 113-121

  Shakarjian, Michael P ^a,b   Velíšková, Jana ^a   Stanton, Patric K ^a   Velíšek, Libor ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Convulsions; GABA; Neurotoxicity; NMDA; Rodenticide; Seizures; Terrorism; Tetramethylenedisulfotetramine

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DIAZEPAM; DIZOCILPINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RODENTICIDE; TETRAMETHYLENEDISULFOTETRAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CLONIC SEIZURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; LETHALITY; LOW DRUG DOSE; MALE; MOUSE; MUSCLE TWITCH; NONHUMAN; SEIZURE; SINGLE DRUG DOSE; TONIC CLONIC SEIZURE;

ANIMALS; ANTICONVULSANTS; CONVULSANTS; DIAZEPAM; DIZOCILPINE MALEATE; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID ANTAGONISTS; KETAMINE; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, GABA-A; RECEPTORS, N-METHYL-D-ASPARTATE; RODENTICIDES; SEIZURES; SESQUITERPENES;

MUS;

EID: 84867825308     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.08.037     Document Type: Article

References (44)

1. Barrueto F., Furdyna P.M., Hoffman R.S., Hoffman R.J., Nelson L.S. Status epilepticus from an illegally imported Chinese rodenticide: "tetramine". J. Toxicol. Clin. Toxicol. 2003, 41:991-994.
2. Browning R.A., Nelson D.K. Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections. Exp. Neurol. 1986, 93:546-556.
3. Bullard R.W. Residue, recovery, determination of translocated tetramine in foliage by hydrogen-flame gas chromatography. J. Agric. Food Chem. 1966, 14:137-139.
4. Casida J.E., Eto M., Moscioni A.D., Engel J.L., Milbrath D.S., Verkade J.G. Structure-toxicity relationships of 2,6,7-trioxabicyclo(2.2.2)octanes and related compounds. Toxicol. Appl. Pharmacol. 1976, 36:261-279.
5. Centers for Disease Control and Prevention (CDC) Poisoning by an illegally imported Chinese rodenticide containing tetramethylenedisulfotetramine-New York City, 2002. MMWR Morb. Mortal. Wkly Rep. 2003, 52:199-201.
6. Chau C.M., Leung A.K., Tan I.K. Tetramine poisoning. Hong Kong Med. J. 2005, 11:511-514.
7. Cole L.M., Sanders M., Palmer C.J., Casida J.E. Structure-biodegradability relationships of insecticidal 1,4-disubstituted-2,6,7-trioxabicyclo2[. 2.2]octanes. J. Agric. Food Chem. 1991, 39:560-565.
8. Croddy E. Rat poison and food security in the People's Republic of China: focus on tetramethylene disulfotetramine (tetramine). Arch. Toxicol. 2004, 78:1-6.
9. Das S.C. Antagonism of evipan by picrotoxin, coramine, and cardiazol. Exp. Physiol. 1939, 29:355-365.
10. De Jager L.S., Perfetti G.A., Diachenko G.W. Comparison of membrane assisted solvent extraction, stir bar sorptive extraction, and solid phase microextraction in analysis of tetramine in food. J. Sep. Sci. 2009, 32:1081-1086.
11. A receptor shapes unique pharmacological profiles. Drug Discov. Today 2009, 14:866-875.
12. Dimock E.J. A comparison of two rodent repellents in broadcast seeding Douglas-fir. USDA Forest Service Old Series Research Notes 1957, No. 20:1-17.
13. Duff D.M., Dille J.M. Distribution and rate of elimination of picrotoxin. J. Pharmacol. Exp. Ther. 1939, 67:353-357.
14. Flomenbaum N., Goldfrank L., Hoffman R., Howland M., Lewin N., Nelson L. Goldfrank's Toxicologic Emergencies 2006, McGraw-Hill, New York. 8th ed.
15. Haskell A.R., Voss E. The pharmacology of tetramine (tetraethylenedisulfotetramine). J. Am. Pharm. Assoc. Am. Pharm. Assoc. (Baltim) 1957, 46:239-242.
16. Hevers W., Hadley S.H., Luddens H., Amin J. Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits. J. Neurosci. 2008, 28:5383-5393.
17. Jett D.A., Yeung D.T. The CounterACT Research Network: basic mechanisms and practical applications. Proc. Am. Thorac. Soc. 2010, 7:254-256.
18. Kramer A.H. Early ketamine to treat refractory status epilepticus. Neurocrit. Care 2012, 16:299-305.
19. Li J.M., Gan J., Zeng T.F., Sander J.W., Zhou D. Tetramethylenedisulfotetramine intoxication presenting with de novo status epilepticus: a case series. Neurotoxicology 2012, 33:207-211.
20. Lu Y., Wang X., Yan Y., Xiao Z., Stephani U. Nongenetic cause of epileptic seizures in 2 otherwise healthy Chinese families: tetramine-case presentation and literature survey. Clin. Neuropharmacol. 2008, 31:57-61.
21. Milbrath D.S., Engel J.L., Verkade J.G., Casida J.E. Structure-toxicity relationships of 1-substituted-4-alkyl-2,6,7-trioxabicyclo[2.2.2.]octanes. Toxicol. Appl. Pharmacol. 1979, 47:287-293.
22. Musteata F.M., de Lannoy I., Gien B., Pawliszyn J. Blood sampling without blood draws for in vivo pharmacokinetic studies in rats. J. Pharm. Biomed. Anal. 2008, 47:907-912.
23. Obata T., Yamamura H.I., Malatynska E., Ikeda M., Laird H., Palmer C.J., Casida J.E. Modulation of gamma-aminobutyric acid-stimulated chloride influx by bicycloorthocarboxylates, bicyclophosphorus esters, polychlorocycloalkanes and other cage convulsants. J. Pharmacol. Exp. Ther. 1988, 244:802-806.
24. Poon W.T., Chan K., Lo M.H., Yip K.K., Lee T., Chan A.Y. A case of tetramine poisoning: a lethal rodenticide. Hong Kong Med. J. 2005, 11:507-509.
25. Ratra G.S., Kamita S.G., Casida J.E. Role of human GABA(A) receptor beta3 subunit in insecticide toxicity. Toxicol. Appl. Pharmacol. 2001, 172:233-240.
26. Raza M., Blair R.E., Sombati S., Carter D.S., Deshpande L.S., DeLorenzo R.J. Evidence that injury-induced changes in hippocampal neuronal calcium dynamics during epileptogenesis cause acquired epilepsy. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:17522-17527.
27. Sasaki K., Furusawa S., Takayanagi G. Effect of doxapram on the action of other drugs and the hepatic drug-metabolizing system in mice. Jpn. J. Pharmacol. 1982, 32:699-707.
28. Schmidt W.J., Kretschmer B.D. Behavioural pharmacology of glutamate receptors in the basal ganglia. Neurosci. Biobehav. Rev. 1997, 21:381-392.
29. Soto-Otero R., Mendez-Alvarez E., Sierra-Paredes G., Galan-Valiente J., Aguilar-Veiga E., Sierra-Marcuno G. Simultaneous determination of the two components of picrotoxin in serum by reversed-phase high-performance liquid chromatography with application to a pharmacokinetic study in rats. J. Pharm. Biomed. Anal. 1989, 7:369-375.
30. Traynelis S.F., Wollmuth L.P., McBain C.J., Menniti F.S., Vance K.M., Ogden K.K., Hansen K.B., Yuan H., Myers S.J., Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol. Rev. 2010, 62:405-496.
31. Velíšek L., Mareš P. Anticonvulsant action of ketamine in laboratory animals. Status of Ketamine in Anesthesiology 1990, 541-549. NPP Books, Ann Arbor, MI. E.F. Domino (Ed.).
32. Velíšek L., Kusá R., Kulovaná M., Mareš P. Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis: I. The effects of 2-amino-7-phosphonoheptanoate. Life Sci. 1990, 46:1349-1357.
33. Velíšková J. Behavioral characterization of seizures in rats. Models of Seizures and Epilepsy 2006, 601-611. Elsevier Press, Burlington VT. A. Pitkanen, P.A. Schwartzkroin, S.L. Moshe (Eds.).
34. Velíšková J., Velíšek L.S. Picrotoxin-induced tonic-clonic seizures and lethality are decreased by MK-801 in developing rats. Pharmacol. Biochem. Behav. 1992, 43:291-295.
35. Velíšková J., Velíšek L., Mares P., Rokyta R. Ketamine suppresses both bicuculline- and picrotoxin-induced generalized tonic-clonic seizures during ontogenesis. Pharmacol. Biochem. Behav. 1990, 37:667-674.
36. Vezzani A., Serafini R., Stasi M.A., Caccia S., Conti I., Tridico R.V., Samanin R. Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. J. Pharmacol. Exp. Ther. 1989, 249:278-283.
37. Voss E., Haskell A.R., Gartenberg L. Reduction of tetramine toxicity by sedatives and anticonvulsants. J. Pharm. Sci. 1961, 50:858-860.
38. Walker M.C., Tong X., Brown S., Shorvon S.D., Patsalos P.N. Comparison of single- and repeated-dose pharmacokinetics of diazepam. Epilepsia 1998, 39:283-289.
39. Wasterlain C.G., Liu H., Naylor D.E., Thompson K.W., Suchomelova L., Niquet J., Mazarati A.M., Baldwin R.A. Molecular basis of self-sustaining seizures and pharmacoresistance during status epilepticus: the receptor trafficking hypothesis revisited. Epilepsia 2009, 50(Suppl. 12):16-18.
40. Wegener N., Nagel J., Gross R., Chambon C., Greco S., Pietraszek M., Gravius A., Danysz W. Evaluation of brain pharmacokinetics of (+)MK-801 in relation to behaviour. Neurosci. Lett. 2011, 503:68-72.
41. Whitlow K.S., Belson M., Barrueto F., Nelson L., Henderson A.K. Tetramethylenedisulfotetramine: old agent and new terror. Ann. Emerg. Med. 2005, 45:609-613.
42. Yen W., Williamson J., Bertram E.H., Kapur J. A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus. Epilepsy Res. 2004, 59:43-50.
43. Zhang Y., Su M., Tian D.P. Tetramine poisoning: a case report and review of the literature. Forensic Sci. Int. 2011, 204:e24-e27.
44. Zolkowska D., Banks C.N., Dhir A., Inceoglu B., Sanborn J.R., McCoy M.R., Bruun D.A., Hammock B.D., Lein P.J., Rogawski M.A. Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine. J. Pharmacol. Exp. Ther. 2012, 341:435-446.